Nadav Kidron
2018
In 2018, Nadav Kidron earned a total compensation of $1.6M as President and Chief Executive Officer and director at Oramed Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Bonus | $148,795 |
|---|---|
| Option Awards | $522,569 |
| Salary | $436,310 |
| Other | $442,326 |
| Total | $1,550,000 |
Kidron received $522.6K in option awards, accounting for 34% of the total pay in 2018.
Kidron also received $148.8K in bonus, $436.3K in salary and $442.3K in other compensation.
Rankings
In 2018, Nadav Kidron's compensation ranked 7,003rd out of 14,244 executives tracked by ExecPay. In other words, Kidron earned more than 50.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,003 out of 14,244 | 51st |
Division Manufacturing | 2,691 out of 5,759 | 53rd |
Major group Chemicals And Allied Products | 1,013 out of 2,122 | 52nd |
Industry group Drugs | 852 out of 1,811 | 53rd |
Industry Pharmaceutical Preparations | 663 out of 1,385 | 52nd |
Source: SEC filing on August 6, 2019.
Kidron's colleagues
We found two more compensation records of executives who worked with Nadav Kidron at Oramed Pharmaceuticals in 2018.